Surface Oncology to Present at Two Upcoming Healthcare Conferences

NEXT STORY
Agios Announces the Randomized Phase 3 ClarIDHy Trial of TIBSOVO® (ivosidenib) Achieved its Primary Endpoint in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients
PREV STORY
Antibody Production Market To Reach USD 26.16 Billion By 2026 | Reports And Data
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Medical Devices Market Size | Is Expected to Gain Momentum by Reaching USD 657.98 Billion by 2028, While Exhibiting a CAGR of 5.4%

author_avatar
NASDAQ Market News

Foamix Announces Completion of Enrollment in Phase 2 Clinical Trial of Minocycline Foam (FMX103) for Treatment of Papulopustular Rosacea

REHOVOT, Israel and BRIDGEWATER, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. ...

author_avatar
NASDAQ Market News

PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio

author_avatar
NASDAQ Market News